A MULTICENTER, MULTIPLE-DOSE, TWO-ARM, ACTIVE-CONTROLLED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO COMPARE THE THERAPEUTIC EFFICACY AND SAFETY OF ORAL DOSES OF CINACALCET HCL WITH INTRAVENOUS DOSES OF AMG 416 IN HEMODIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM
- Registry ID
- 20120360
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- AMGEN CANADA INC
- Start date
- 2014-03-21
- Last update
- 2013-06-13
Conditions
- SECONDARY HYPERPARATHYROIDISM
View on source registry